{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:11:44Z","timestamp":1791321104462,"version":"4.3.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T00:00:00Z","timestamp":1201651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2,16]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Haematopoietic stem cell transplantation is often complicated by the life-threatening graft-versus-host disease (GVHD) which consists of an allogeneic reaction of the graft cells against the host organs. The aim of this study was to investigate the putative involvement of soluble human leucocyte antigen (sHLA) class I molecules, and particularly sHLA-G molecules, in the occurrence and\/or prevention of acute GVHD (aGVHD) in allogeneic peripheral blood stem cell (PSC) transplantation. Whole sHLA class I molecules seem to be involved in aGVHD pathogenesis because detection of a high concentration of these molecules in the first month post allograft is correlated with aGVHD occurrence. Conversely, a high level of sHLA-G molecules before and after allograft could indicate good prognosis in PSC allograft transplantation. sHLA-G molecules seem to be involved in aGVHD prevention, not only because they are enriched in plasma of patients without aGVHD, but also because: (i) a positive correlation has been found between sHLA-G level and CD4+ CD25+\u2003CD152+ natural regulatory T cell (Treg) frequency in the blood of transplanted patients; and (ii) the presence of CD4+\u2003CD25+\u2003CD152+ natural Treg is correlated with increased sHLA-G expression in in vitro mixed leucocyte reaction cultures. Altogether, these results support the immunomodulatory function of sHLA-G molecules that might create a regulatory network together with the natural Treg to foster the induction of a tolerogenic environment and improve PSC transplantation favourable outcome.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2008.03598.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T22:45:00Z","timestamp":1280184300000},"page":"50-56","source":"Crossref","is-referenced-by-count":42,"title":["Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-<i>versus<\/i>-host disease and a link with regulatory T cells"],"prefix":"10.1093","volume":"152","author":[{"given":"A","family":"Le Maux","sequence":"first","affiliation":[{"name":"UPRES EA 3889 Immunologie\/H\u00e9matologie, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Rennes 1, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"No\u00ebl","sequence":"additional","affiliation":[{"name":"UPRES EA 3889 Immunologie\/H\u00e9matologie, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Rennes 1, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Birebent","sequence":"additional","affiliation":[{"name":"Etablissement Fran\u00e7ais du Sang Bretagne \u00a0France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-M","family":"Grosset","sequence":"additional","affiliation":[{"name":"Etablissement Fran\u00e7ais du Sang Bretagne \u00a0France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Vu","sequence":"additional","affiliation":[{"name":"UPRES EA 3889 Immunologie\/H\u00e9matologie, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Rennes 1, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"De Guibert","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie Clinique, CHU de Rennes, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bernard","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie Clinique, CHU de Rennes, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Semana","sequence":"additional","affiliation":[{"name":"UPRES EA 3889 Immunologie\/H\u00e9matologie, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Rennes 1, France"},{"name":"Etablissement Fran\u00e7ais du Sang Bretagne \u00a0France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Amiot","sequence":"additional","affiliation":[{"name":"UPRES EA 3889 Immunologie\/H\u00e9matologie, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Rennes 1, France"},{"name":"Service d'H\u00e9matologie Clinique, CHU de Rennes, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,1,30]]},"reference":[{"key":"2022010405174803200_b1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V36.4.507.507","article-title":"Technique for human marrow grafting","volume":"36","author":"Thomas","year":"1970","journal-title":"Blood"},{"key":"2022010405174803200_b2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1537-2995.1999.39199116893.x","article-title":"Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte\u2013macrophage- and granulocyte\u2013colony-stimulating factors","volume":"39","author":"Lane","year":"1999","journal-title":"Transfusion"},{"key":"2022010405174803200_b3","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1046\/j.1537-2995.2001.41080988.x","article-title":"In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion?","volume":"41","author":"Ghio","year":"2001","journal-title":"Transfusion"},{"key":"2022010405174803200_b4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0198-8859(97)00038-4","article-title":"HLA-G gene polymorphism segregation within CEPH reference families","volume":"53","author":"Kirszenbaum","year":"1997","journal-title":"Hum Immunol"},{"key":"2022010405174803200_b5","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0198-8859(00)00197-X","article-title":"Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5-G6, and -G7 transcripts in human transfected cells","volume":"61","author":"Paul","year":"2000","journal-title":"Hum Immunol"},{"key":"2022010405174803200_b6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0198-8859(03)00093-4","article-title":"Soluble nonclassical HLA generated by the metalloproteinase pathway","volume":"64","author":"Dong","year":"2003","journal-title":"Hum Immunol"},{"key":"2022010405174803200_b7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1096\/fj.04-2078rev","article-title":"HLA-G and immune tolerance in pregnancy","volume":"19","author":"Hunt","year":"2005","journal-title":"FASEB J"},{"key":"2022010405174803200_b8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.autrev.2005.04.006","article-title":"Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology","volume":"4","author":"LeMaoult","year":"2005","journal-title":"Autoimmun Rev"},{"key":"2022010405174803200_b9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.humimm.2003.08.356","article-title":"Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver\u2013kidney transplantation: possible implications for monitoring patients","volume":"64","author":"Creput","year":"2003","journal-title":"Hum Immunol"},{"key":"2022010405174803200_b10","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.0000015075.89984.46","article-title":"Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection","volume":"105","author":"Lila","year":"2002","journal-title":"Circulation"},{"key":"2022010405174803200_b11","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1600-6143.2006.01417.x","article-title":"Soluble HLA-G expression and renal graft acceptance","volume":"6","author":"Qiu","year":"2006","journal-title":"Am J Transplant"},{"key":"2022010405174803200_b12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0165-0378(00)00070-X","article-title":"HLA-G suppresses proliferation of CD4(+) T-lymphocytes","volume":"48","author":"Bainbridge","year":"2000","journal-title":"J Reprod Immunol"},{"key":"2022010405174803200_b13","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1073\/pnas.94.10.5249","article-title":"The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010405174803200_b14","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.168.9.4772","article-title":"A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape","volume":"168","author":"Wiendl","year":"2002","journal-title":"J Immunol"},{"key":"2022010405174803200_b15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/immu.200390015","article-title":"Soluble HLA-A, -B, -C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation","volume":"33","author":"Contini","year":"2003","journal-title":"Eur J Immunol"},{"key":"2022010405174803200_b16","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L","article-title":"HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor","volume":"32","author":"Liang","year":"2002","journal-title":"Eur J Immunol"},{"key":"2022010405174803200_b17","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1073\/pnas.0401922101","article-title":"HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells","volume":"101","author":"LeMaoult","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010405174803200_b18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2006-11-057125","article-title":"HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation","volume":"110","author":"Feger","year":"2007","journal-title":"Blood"},{"key":"2022010405174803200_b19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"2022010405174803200_b20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"2022010405174803200_b21","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/eji.200324632","article-title":"Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression","volume":"34","author":"Birebent","year":"2004","journal-title":"Eur J Immunol"},{"key":"2022010405174803200_b22","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.193.11.1303","article-title":"Ex vivo isolation and characterization of CD4(+) CD25(+) T cells with regulatory properties from human blood","volume":"193","author":"Dieckmann","year":"2001","journal-title":"J Exp Med"},{"key":"2022010405174803200_b23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.humimm.2003.08.345","article-title":"Soluble HLA-G molecules are increased in lymphoproliferative disorders","volume":"64","author":"Sebti","year":"2003","journal-title":"Hum Immunol"},{"key":"2022010405174803200_b24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.humimm.2005.05.003","article-title":"Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004","volume":"66","author":"Rebmann","year":"2005","journal-title":"Hum Immunol"},{"key":"2022010405174803200_b25","first-page":"753","article-title":"Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD","volume":"17","author":"Puppo","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"2022010405174803200_b26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0268-960X(03)00009-2","article-title":"Immunobiology of acute graft-versus-host disease","volume":"17","author":"Reddy","year":"2003","journal-title":"Blood Rev"},{"key":"2022010405174803200_b27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0198-8859(02)00461-5","article-title":"Interferon-gamma drives the metalloproteinase-dependent cleavage of HLA class I soluble forms from primary human bronchial epithelial cells","volume":"63","author":"Haynes","year":"2002","journal-title":"Hum Immunol"},{"key":"2022010405174803200_b28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bmt.1700877","article-title":"Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease","volume":"20","author":"Liem","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"2022010405174803200_b29","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.4049\/jimmunol.176.5.3266","article-title":"Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive\/regulatory T cells","volume":"176","author":"Le Rond","year":"2006","journal-title":"J Immunol"},{"key":"2022010405174803200_b30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.humimm.2006.11.008","article-title":"Mechanisms of prolongation of allograft survival by HLA-G\/ILT4-modified dendritic cells","volume":"68","author":"Ristich","year":"2007","journal-title":"Hum Immunol"},{"key":"2022010405174803200_b31","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2006-02-003996","article-title":"High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT","volume":"108","author":"Rezvani","year":"2006","journal-title":"Blood"},{"key":"2022010405174803200_b32","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1073\/pnas.201407398","article-title":"Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism","volume":"98","author":"Lila","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010405174803200_b33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/eji.200324266","article-title":"Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients","volume":"34","author":"Le Rond","year":"2004","journal-title":"Eur J Immunol"},{"key":"2022010405174803200_b34","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.humimm.2003.08.354","article-title":"Detection of HLA-G5 secreting cells","volume":"64","author":"Rebmann","year":"2003","journal-title":"Hum Immunol"},{"key":"2022010405174803200_b35","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.molimm.2006.01.007","article-title":"Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells","volume":"43","author":"Lopez","year":"2006","journal-title":"Mol Immunol"},{"key":"2022010405174803200_b36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1471-4906(03)00072-3","article-title":"Tolerance, DCs and tryptophan: much ado about IDO","volume":"24","author":"Grohmann","year":"2003","journal-title":"Trends Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03598.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03598.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/152\/1\/50\/42045407\/j.1365-2249.2008.03598.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/152\/1\/50\/42045407\/j.1365-2249.2008.03598.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:21:11Z","timestamp":1685701271000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/152\/1\/50\/6457565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,30]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,1,30]]},"published-print":{"date-parts":[[2008,2,16]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03598.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,4]]},"published":{"date-parts":[[2008,1,30]]}}}